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ScienceDirectInfluenza represents a serious threat to public health with
thousands of deaths each year. A deeper understanding of the
host–pathogen interactions is urgently needed to evaluate
individual and population risks for severe influenza disease and
to identify new therapeutic targets. Here, we review recent
progress in large scale omics technologies, systems genetics
as well as new mathematical and computational developments
that are now in place to apply a systems biology approach for a
comprehensive description of the multidimensional host
response to influenza infection. In addition, we describe how
results from experimental animal models can be translated to
humans, and we discuss some of the future challenges ahead.
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Introduction
Every year, about 500 million people worldwide are
infected with the influenza A virus (IAV), and about
0.5 million die from the infection. The most severe
pandemic in 1918 resulted in about 30–50 million deaths
worldwide. Newly emerging H5N1 and H7N9 avian IAV
cause lethal infections in humans but have not yet
acquired the potential to spread from human to human.
Our options for treatment of IAV infections are very
limited since only two drugs for therapeutic interventions
are available, and resistance to both has been observed.
Furthermore, no reliable biomarkers exist for early pre-§ This is an open-access article distributed under the terms of the
Creative Commons Attribution-NonCommercial-ShareAlike License,
which permits non-commercial use, distribution, and reproduction in
any medium, provided the original author and source are credited.
www.sciencedirect.com diction of severe progression of disease, co-infection or
host risk factors. Classical virology has mostly investi-
gated molecular mechanisms at the cellular level, such as
adhesion, entry, replication and assembly of viruses.
However, not only viral but also many host factors, like
the quality and quantity of immune cell responses, bac-
terial co-infections, genetic predisposition and other
health risks are crucial determinants for the course of
an infection and potential lethal outcomes.
Thus, it is necessary to identify the host factors that are
required to successfully fight an infection or that cause
adverse responses. For this, a highly integrated research
strategy is needed to understand all aspects of the com-
plex interplay between the host and invading pathogen.
This systematic approach has to go way beyond in vitro
cell culture systems and needs to address all aspects of
host–virus interactions at the molecular, cellular, organ,
and organism level.
In this review, we summarize recent advances in omics
data collection and systems genetics that were used to
reveal crucial molecular interaction networks. In addition,
we describe how systems biology in experimental models
should be combined with analyses in patients to create
predictive in silico models for humans, and we address
some of the challenges that still need to be solved.
Omics data as the basis for systems biology
The first necessary step for a systems biology approach
(Figure 1) is the gathering of large amounts of data that
should be as comprehensive as possible. Analysis of the
transcriptome is presently one of the few omics technol-
ogies that can be easily performed, and that records all
changes for all annotated, transcribed regions.
Global gene expression changes using microarrays have
been investigated in lungs of mice, ferrets or macaques
after infection with different IAV subtypes and variants
[1–4,5,6–12]. Also, the expression of miRNAs has been
studied [13–15]. Thus far, only few studies have used
high-throughput RNA sequencing (RNAseq) for anal-
yses of the host transcriptome after IAV infection
[9,11,12] but more may be expected in the near future,
because this new technology has several advantages, for
example the analysis of virus gene expression in parallel
with host genes. The overall conclusions from these
transcriptome analyses were that the induced hostCurrent Opinion in Virology 2014, 6:47–54
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Systems analysis approach to study host–pathogen interactions during
influenza infection. Infection by influenza A virus causes massive
perturbation of the biological system (host). Here, infection dose and
virulence of the virus are the most important variables. In addition, other
influences, such as environment (diet, exposure) and host risk factors
(age, sex, life style, co-morbidities) also influence the systems response.
These variables and influences can be standardized and modified in a
controlled fashion in animal models, whereas in humans they represent
unknown confounding factors. Host genetic variations represent another
host factor modifying the system response. It can be exploited in a
systems biology approach in animal models as an additional controlled
variable to systematically perturb the system. All perturbations result in
systems responses which can be recorded at the level of transcriptome,
proteome, metabolome and clinical parameters (body weight loss,
survival, viral load, or immune response). Based on these large data
sets, mathematical and computational methods are used to develop in
silico models of host–pathogen interactions. The in silico models then
allow for development of hypotheses about crucial networks, hubs,
bottlenecks which are validated in animal models and humans, and then
refined. The ultimate outcome of a systems biology approach is the
identification of new targets and strategies for prevention, diagnosis, risk
assessment and treatment of severe influenza disease in humans.inflammatory response correlates with the severity of
disease and depends on viral subtype and strain, viral
dose and host genetic background. Severe and mild
infections do not differ much in the type of activated
genes, but rather in the magnitude of up-regulation of
host response genes. Infections with highly pathogenic
viruses resulted in an earlier and more sustained up-
regulation of inflammatory genes (reviewed in [16,17]).Current Opinion in Virology 2014, 6:47–54 Thus, in infections with a severe outcome, both virus
spread and a strong host immune response result in the
destruction of lung cells and eventually the failure of the
respiratory system [18].
The first studies in experimental models that use more
advanced mathematical and computational methods for
the analysis of host–pathogen interactions have just been
published. Integration of phenotypic and transcriptomic
data from H1N1-infected mice identified sets of tran-
script modules that correlate with body weight, clinical
score, viral load, histopathology, and weight loss at day 4
post infection [5]. Another study used expression data
from pre-CC lines with extreme phenotypes, expression
quantitative trait loci (eQTL) mapping and structural
equation modeling. The authors identified three genes
that were highly connected with putative causal corre-
lations to many other genes in the lungs of H1N1 infected
mice [6]: Ifi27l2a related to downstream genes involved in
signal transduction and transportation, Sh3gl3 to cellular
growth and development genes, and Kcmf1 to genes
involved in metabolic processes. However, the role and
contribution of other loci is less clear and interpretation is
often limited because of poor annotations of the respect-
ive genes. Thus, a broad analysis of gene functions, for
example large scale phenotyping in mouse knock-out
mutants, is urgently needed to close this knowledge
gap [19,20]. Other studies related transcriptome analysis
with clinical, histopathological and viral parameters in
macaques [21,22]. Clinical signs were consistent with
those observed in humans and transcriptional changes
revealed activation of the interferon pathways and innate
immune responses as well as mediators for cell migration
that related to the activation of inflammatory cells, his-
topathological signs of inflammation and tissue damage
[22]. First transcriptional changes were observed after 6 h,
inflammatory, antiviral and apoptotic genes were up-
regulated after 12 h, and a shift to acquired immunity
was observed after day 6 post infection [22].
Almost all studies thus far have concentrated on the innate
phase of the host response. Only one publication presented
a long-term time series transcriptome analysis for up to 60
days post infection in lungs after a non-lethal H1N1 in-
fection in mice [23]. In this publication, the different
phases of the host response to an influenza infection were
described as temporal changes in gene expression patterns.
Further analysis of the time-series data using dynamic and
time-varying gene regulatory network methodologies
revealed the role of cell cycle genes both in innate and
adaptive immunity. The pathogen–sensory pathways (e.g.
RIG-I, NOD-like) showed a long-lasting association with
other innate immune responses (e.g. NK cell cytotoxicity,
cytokine/chemokine signaling [24]).
Global gene expression profiles were also used to deter-
mine sets of signature genes that are indicative of an IAVwww.sciencedirect.com
Systems biology influenza Kollmus, Wilk and Schughart 49infection. One report has collected results from various
experimental studies in mice infected with either highly
pathogenic H5N1, reconstructed 1918 influenza A virus
or SARS, and has defined a set of influenza-specific
signature genes by meta-analysis [25]. Another study
described a set of 10 host signature genes that identified
the infecting IAV strain in ferrets [10]. Moreover, the
analysis of blood cell transcriptomes in experimentally
infected volunteers revealed a set of influenza-specific
signature genes in humans [26,27,28]. Furthermore, a
clinical investigation in patients with severe pneumonia
has identified blood transcriptome signatures that dis-
tinguish IAV from other respiratory infections [29,30].
In addition, global gene expression profiles were used to
follow immune cell infiltration in an infected lung by
using cell-type specific gene expression profiles [23,31].
These studies revealed that the infiltration of lymphoid
cells can be followed by signature genes whereas it is
more difficult to obtain profiles for myeloid cells. Recent
attempts to create a comprehensive set of specific signa-
ture genes for immune cell populations should facilitate
this approach in the future [32].
Proteomics or combined proteome and transcriptome
analyses in experimental IAV infections of macaques
demonstrated that in most cases changes at the transcrip-
tional and protein levels were highly correlated. Also,
some differences were found emphasizing the need for
complementary proteome analyses [33,34]. Studies in
H5N1-infected mice revealed that the host response,
after infection with viruses of different virulence, mainly
differed in the magnitude and velocity of the host
response kinetics, rather than specific sets of regulated
host genes [35].
Furthermore, bioactive lipid mediators have been ana-
lyzed by liquid chromatography/mass spectrometry and
the results were integrated with gene expression. Data
generated from animal studies as well as human patients,
showed an increase in 5-lipoxygenase metabolites that
correlated with the pathogenic phase, whereas 12/15-
lipoxygenase metabolites were increased during the
resolution phase [36].
The most advanced systems biology approach in which a
full circle of omics studies, modeling, prediction of inter-
actions, formulation of a hypothesis and finally exper-
imental testing of the hypothesis has been performed was
reported recently [37]. The authors combined transcrip-
tome with imaging and flow cytometry studies in mice
and identified a chemokine-driven feed-forward circuit
that triggered strong neutrophil responses in lethally
infected mice. They then validated their findings by
showing that experimental attenuation of neutrophil
responses resulted in reduction of tissue damage and
increased survival.www.sciencedirect.com In conclusion, systems biology for influenza host–pathogen
interactions in experimental animal models has just begun.
The first integrated studies and network analyses have
clearly demonstrated the advantage of a systems biology
approach to better understand the complexity and multi-
tude of host–pathogen interactions and to predict disease
outcome. Although major challenges lie ahead, systems
biology offers strong potential for new discoveries.
Systems genetics — an important new avenue
Systems genetics represents a new approach to evaluate
the contribution of host genetics to the outcome of
infectious diseases. Multiple phenotypes are collected
in a genetic reference population (GRP) and sub-
sequently associated with genetic variations. Using this
approach, genomic regions (quantitative trait loci, QTLs)
that regulate a given phenotypic trait can be identified.
Many traits, including molecular omics data such as
transcriptomes and proteomes can be collected on the
same GRP. In this way, systems genetics connects traits
with genes and gene networks, and will therefore become
an important element in systems biology. Furthermore,
systems genetics represents a hypothesis-free experimen-
tal approach in which completely new and previously
unknown associations can be discovered.
The BXD and the AXB/BXA mouse strain collections are
two GRPs that were created from two parental mouse
strains. BXD are a set of recombinant inbred strains from
C57BL/6J and DBA/2J as parents [38]. AXB/BXA
represents a collection of recombinant congenic strains
derived from A/J and C57BL/6J [39]. Analyses of these
GRPs identified several QTLs after infection with H1N1,
H3N2 or H5N1 [40–43]. Five QTLs on chromosomes 2,
7, 11, 15 and 17 associated with body weight loss and
survival after infection of BXD strains with H5N1 virus
[41], and the hemolytic complement gene (Hc) located in
the chromosome 2 QTL was subsequently shown to
influence viral titer at day 7 post infection. Infection of
53 BXD strains with H1N1 identified two significant
QTLs on chromosomes 5 and 19 that regulated body
weight loss, survival and mean time to death in a time-
dependent manner [42]. Infection of 29 AcB/BcA recom-
binant congenic strains with mouse-adapted H3N2 virus
revealed sex-specific clinical QTLs for survival on
chromosomes 2 and 17 [40]. Using cis-eQTLs as a means
to search for the most likely quantitative trait genes, the
authors identified also Hc as a candidate on chromosome
2, and Tnfrsf21 and Pla2g7 in the chromosome 17 QTL
intervals. Further studies with more mice and congenic
lines will be required in the future to identify additional
quantitative trait genes and to confirm their causal role. In
this context, it is important to note that the results from
these GRPs have been deposited in a publically available
database, GeneNetwork [44], that greatly facilitates the
correlation of influenza host responses to thousands of
other phenotypes and transcriptomes.Current Opinion in Virology 2014, 6:47–54
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Generation of the Collaborative Cross resource. The Collaborative Cross (CC) [45,67] is the result of a ten-year collaborative effort by the mouse
genetics community to create a large, genetically highly diverse population (CC lines) for phenotyping and mapping studies. The population has been
generated from eight founder strains, A/J, C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ, NZO/HlLtJ, WSB/EiJ, PWK/PhJ, and CAST/EiJ (Photo: Brynn H. Voy,
University of Tennessee). These strains represent the three major Mus musculus subspecies: M. m. domesticus, M. m. musculus, and M. m. castaneus.
Five of the founder strains are common laboratory strains, and three are wild-derived inbred strains. After inbreeding of the founder strains for two
generations, and subsequent inbreeding for more than 20 generations (breeding scheme: [45] with permission of the Genetics Society of America) has
resulted in the generation of CC lines (http://csbio.unc.edu/CCstatus/). The genetic diversity of the CC lines is similar to that of the human population
and thus represents an unprecedented and unique resource for genetic mapping and correlation studies [45,68].The Collaborative Cross (CC [45]) is a novel mouse GRP
with unprecedented genotypic and phenotypic variation
generated from eight founder strains, including three
wild-derived strains (Figure 2). The CC population is
genetically as diverse as the human population. This
resource has just become available, and we can expect
the first results to appear within the next years. In the
meantime, several research groups have started to phe-
notype mice from emerging CC lines (pre-CC lines) that
were not yet fully inbred. Analysis of the host responses at
day 4 post infection with IAV , such as inflammation, viral
replication, body weight loss and survival studies ident-
ified several QTLs regulating body weight loss, viral titer,
pulmonary edema, neutrophil recruitment and expression
levels of host genes [5]. A highly significant QTL on
chromosome 16 that explained most of the phenotypic
variance for body weight loss contained the well-known
Mx1 resistance gene representing the most likely candi-
date. A surprising finding was that the wild-derived
CAST/EiJ founder strain carrying a presumably func-Current Opinion in Virology 2014, 6:47–54 tional Mx1 allele showed reduced ability to inhibit viral
replication at day 4 post infection [5]. Additional
significant QTLs were identified on chromosome 7 after
controlling for the Mx1 QTL and on chromosome 1 by
performing a mapping analysis only in the subpopulation
that carried a non-functional Mx1 allele. Furthermore,
immunophenotyping of 66 pre-CC lines and the CC
founder strains revealed highly significant QTLs control-
ling B/T cell ratio, CD8 T-cell numbers, and expression
of CD11c and CD23. The CD23 regulating QTL
represented a cis-QTL containing the CD23 encoding
gene Fcer2a [46]. Thus, it should soon be possible to
correlate the genetically controlled variations in immune
cells and other phenotypic traits in CC mice with influ-
enza-associated host responses.
In conclusion, systems genetics has collected first sets of
omics data and correlated them with clinical phenotypes.
In the future, we can expect that many more phenotypic
traits will be accumulated from the CC population andwww.sciencedirect.com
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host–pathogen interactions.
From animal models to human patients
The next step will be to translate the knowledge from
systems biology into systems medicine to predict disease
outcome in humans. First omics results from the blood of
humans have been obtained from experimentally
infected volunteers [26,27,28] and from infected
patients [29,30,47]. These studies revealed a pronounced
activation of granulocytes and increase in chemokines
and cytokines. However, studies in human patients are
compromised because they have an uncertain history and
are often confounded by many unknown intrinsic and
extrinsic factors. Furthermore, controlled experimental
infection in human volunteers can only be performed to a
very limited extend for obvious ethical reasons. Therefore,
experimental animal models must lead the way. Initial in
silico models will have to be generated from extensive
datasets obtained in animal models because they allow
collection of large datasets from infected organs and body
fluids simultaneously and at a very high spatial and
temporal resolution. Crucial pathways and players can then
be identified, tested experimentally and finally integrated
with data obtained from human patients.
It should be noted that the value of the mouse as model
system for studying inflammatory responses in humans has
recently been debated [48]. However, in the case of
influenza, the responses in mice are very similar to those
in human and non-human primates, results are very repro-
ducible, and the kinetics of pathological symptoms are
identical. Environmental factors like nutrition, age, sex,
among others and even genetics can be easily controlled in
murine models. A comparative analysis of the transcrip-
tional regulatory networks in human cell culture and
experimental mouse and macaque model systems after
H5N1 infections observed conserved host responses [49].
Similar clinical signs were observed in mouse, macaque
and swine after pH1N1 infection, whereas differences
were detected for the kinetics of expression of inflamma-
tory genes. In addition genes associated with the retinoid X
receptor signaling pathway were found to be differentially
regulated between species [50].
There is an urgent clinical need for biomarkers that allow
predicting the severe course of disease in humans. A
study in patients with severe and mild infections found
elevated levels of MCP-3 and IFNa2 in nasal lavage, and
increased IL-10 levels in plasma, that were correlated
with progression to severe disease [51]. Plasma appeared
to provide a poor reflection of the immune profile in the
lung [51]. Until now, only few omics studies in exper-
imental animal models have been performed from per-
ipheral blood [11], and only a limited number of
chemokines and cytokines have been measured in
broncho-alveolar lavages (BAL). It will now be importantwww.sciencedirect.com to relate and complement these findings by including a
systems approach in animal models where proteome,
transcriptome and metabolome markers in the blood,
broncho-alveolar lavages or nasal washes are measured.
These changes have to be correlated with clinical
parameters as well as with pathology and viral load in
the infected lung. In the future it will be necessary to
address clinical needs more precisely by designing even
more advanced experimental models that offer better
transferability to humans.
The development of more efficient vaccines, especially
for the elderly or very young, is another important goal in
preventing influenza disease in humans. Several studies
systematically profiled host responses to vaccination in
humans [52,53,54]. One report identified early molecular
signatures in the transcriptomes of peripheral blood
monocytes that correlated with induction of hemaggluti-
nin-neutralizing antibody responses [52]. Their theor-
etical model predicted CAMK4 as a negative regulator,
and its function could subsequently be confirmed in
Camk4 knock-out mice. Future systems biology studies
in animal models may contribute substantially to the
development of more efficient vaccines by studying
the host response at the interface of innate and adaptive
immunity in more detail.
In conclusion, the mouse and other experimental animal
models represent excellent systems to use systems
biology for a comprehensive description of host–pathogen
interactions during IAV infections, leading the way to
systems medicine in humans.
Challenges ahead
Clearly, systems biology has entered the field of influenza
virology but there are still major challenges ahead.
Proteomics is as important as transcriptomics for systems
analysis because many signaling pathways are activated
by posttranslational modifications or by protein degra-
dation [55]. However, proteomics (especially at the organ
and tissue level) still has major limitations to overcome,
such as detection of low-abundant species, incomplete
proteome coverage, and narrow dynamic range.
Thus far, we record omics changes at the level of the whole
lung, but we need to understand in which cell types these
changes occur. If we want to understand the cross-talk
between gene signaling pathways and identify crucial
points of connectivity in the network, it will be essential
to know the expression profiles of individual cells and the
quantitative changes of immune cell populations over time
in the infected organ. For this, future developments in
single cell transcriptome, metabolome and proteomics
analysis (reviewed by [56]) (e.g. cells isolated by laser
capture from tissue sections or cell sorting) should provide
a higher resolution that is required for improved modeling.Current Opinion in Virology 2014, 6:47–54
52 Viral pathogenesisVarious computational approaches have been used to
identify relevant host–pathogen-interaction networks in
cell cultures [4,57–63]. These studies represent a highly
valuable knowledge base that will have to be integrated
into in silico models from whole organisms. Thus, a future
challenge will be to develop the appropriate compu-
tational models that enable this integration into a single
model.
Systems genetics builds on the integration of large data
sets which should be easily accessible. The value of meta-
analyses of different studies has recently been demon-
strated by comparing transcriptome results from mice
infected with four different respiratory viruses [25].
There is an urgent need to establish publically available
comprehensive databases. First initiatives for transcrip-
tome data have started [64], and the NIH-funded ‘Sys-
tems Biology Program for Infectious Disease Research’
consortium represents an essential step in this direction
[65]. However, existing resources need to be expanded in
the future to also include results from phenotypic studies
from experimental model systems and humans.
Furthermore, it will be necessary to have a knowledge
base that describes all known interactions at the molecu-
lar and cellular level, and that is constantly updated and
validated by the scientific community. A first influenza
map has been created for host–pathogen interactions at
the level of an infected cell [66]. In the future, it will be
essential to expand these interaction maps to also include
host responses at the level of the whole organism, such as
cross talk between infected epithelial cells and immune
cells, immune cell activation, tissue destruction and tissue
remodeling.
Conclusion
Systems biology of influenza host–pathogen interactions
has just begun. Large data sets have been collected, and
more sophisticated mathematical and computational
approaches are being used to provide a holistic view of
the many molecular and cellular interactions involved,
and to correlate them with clinical outcomes. The ulti-
mate goal is to generate in silico models where crucial
pathways, hubs and bottlenecks can be identified, leading
to new targets and strategies for prevention, diagnosis,
risk assessment and treatment of severe influenza disease
in human. Although there is still a long way to go, exciting
times in this emerging field of systems virology are lying
ahead.
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